Hims Launches Testosterone Replacement Therapy Service

The new service offers men access to testing and treatment for testosterone deficiency via clinical consultation.

Updated on Oct. 21, 2026 in Men’s Health

Flat opaque gouache-painted illustration of a medical lancet and vial, representing modern at-home diagnostic health testing. — Hims has launched a new testosterone replacement therapy service in the United States, providing at-home diagnostic testing and clinical consultations for men. AI Illustration. Upload story photo >

Live Poll

Would you trust a telehealth platform to manage your hormone replacement therapy and medical testing?

Hims has introduced a new testosterone replacement therapy service for men, offering both oral and injectable treatments. The process involves at-home hormone testing via a specialized blood collection device followed by a required clinical video consultation.

Why it matters

The service aims to expand access to testosterone therapy for individuals with diagnosed testosterone deficiency. Because testosterone is a controlled substance regulated under the 1990 Anabolic Steroids Control Act, oversight remains a critical factor in how these treatments are accessed and monitored.

A survey of 2,000 American men commissioned by Hims identified a 35 percent increased mortality risk associated with testosterone deficiency. While the platform utilizes a Tasso device to analyze 21 biomarkers, the effectiveness of this remote screening remains under investigation.

The players

Hims

A digital health company that provides telehealth services and prescriptions for men.

The details

The diagnostic pathway requires patients to use an at-home capillary blood collection device to measure hormone levels. Clinicians then review these results, which cover 21 specific biomarkers, in conjunction with the patient's medical history and current symptoms. If appropriate, they may prescribe one of two injectable treatments or an oral pill to address hormonal imbalances.

1990: Testosterone was classified as a controlled substance.
2017: Hims launched its digital health operations.
October 2026: Hims launched its testosterone replacement therapy service.

Health Landscape

The introduction of this service follows an established trend of expanding digital clinic prescription practices. It operates strictly within the regulatory bounds of the 1990 Anabolic Steroids Control Act, which governs the dispensing of controlled hormones.

If you are concerned about symptoms of low testosterone, the most important step is to speak with your primary care physician to discuss whether testing is appropriate for you. A clinical evaluation is necessary to confirm a diagnosis before any consideration of hormone replacement therapy.

The takeaway

Testosterone replacement therapy is a significant medical intervention that requires professional oversight due to the drug's status as a controlled substance. If you are experiencing symptoms, prioritize a comprehensive physical exam with your doctor to determine the underlying cause.